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Introduction {#sec001}
============

*Chromobacterium violaceum* is abundantly present in the soil and water as microbiota in tropical and subtropical regions around the world. For many years, it was mainly known as a producer of violacein and as a reporter for the discovery of quorum sensing molecules. In recent years, *C*. *violaceum*, primarily a neglected zoonotic pathogen, has emerged as an important model of an environmental opportunistic human pathogen, with a current low incidence of about 150 cases worldwide \[[@pone.0210008.ref001]\]. The high mortality rate (ca. 65--80% \[[@pone.0210008.ref002]\]) of infection with this gram-negative β-proteobacterium, is a result of its unique survival strategies against antibiotics coupled with directed enzyme activities (superoxide dismutase and catalase) to escape host defense \[[@pone.0210008.ref003]\]. Its high virulence in human infections and a mouse infection model involves the possession of several predicted virulence traits, including two type III secretion systems (T3SSs) \[[@pone.0210008.ref004]\]. Further, antibiotic resistance is also a critical factor in chronic infection. One of the defining phenotypes of this pathogen is the vivid metallic purple color, attributable to the blue-violet, non-diffusible pigment violacein produced from the essential amino acid tryptophan. Violacein is a virulence factor and also has documented antibiotic properties \[[@pone.0210008.ref005]\]. The production of violacein is easy to screen and allows one to use this as a model system to study the emergence and control of antibiotic resistance. Understanding complex relationships between genotype and phenotype, using GSMM has become increasingly fundamental to systems biology of pathogens. Availability of the genome sequence of *C*. *violaceum* \[[@pone.0210008.ref006]\] mandates a functional GSMM, as has been reconstructed for multiple pathogens \[[@pone.0210008.ref007]--[@pone.0210008.ref009]\]. Such a GSMM would potentially enable both metabolic engineering of violacein and elucidation of pathogenic and resistance mechanisms.

Antibiotic resistance has become a grand challenge for society and a multipronged approach that addresses surveillance, awareness and scientific mechanisms are required to combat it \[[@pone.0210008.ref010]\]. Our previous study integrating genomics, limited phenomics and metabolomics data \[[@pone.0210008.ref011]\], unraveled disruption of critical redox homeostasis by specific metabolite supplementation causing death of streptomycin resistant (StrpR) and chloramphenicol resistant (ChlR) populations of *C*. *violaceum*. It also highlighted the utility of a core model of metabolism integrated in the context of systems-level data, to generate hypothesis and predict emergent properties of antibiotic resistance.

In this study, the *C*. *violaceum* genome sequence was used to develop a GSMM through an initial automated draft reconstruction using the Model SEED server. The draft reconstruction was translated into a functional mathematical model after manual curation with legacy data and customized biomass macromolecular composition. The model was validated (prediction accuracy of 89%) using legacy BIOLOG data for respiration. Growth on thirty metabolites were predicted and validated experimentally. Glucose uptake rates (GUR), violacein secretion rates (VSR) and ATP maintenance (ATPM) were used as constraints to customize models to represent antibiotic resistant and susceptible phenotypes. Flux variability analysis (FVA) showed metabolic flux redistribution associated with antibiotic resistance in reactions involving redox factors NADH, TCA cycle, glyoxylate shunt and overflow metabolism. FVA also identified fold changes in proton motive force through ATP synthesis proportional to that observed in PMF using flow cytometer. Pareto front analysis was performed to identify tradeoffs between ATP and NADH maintenance using an *in silico* NADH oxidase reaction (NOX) in the growth of the resistant populations *vis a vis* wild type (WT). This study represents *C*. *violaceum in silico* and correlates it's metabolic features to antibiotic resistance and predicts related metabolite vulnerabilities. Such approaches could lead to scalable pipelines using OMICS derived constraints-based flux balance models for clinical isolates.

Results {#sec002}
=======

Genome scale reconstruction and model statistics {#sec003}
------------------------------------------------

The draft reconstruction was obtained from Model SEED based on genome sequence of ATCC 12472 strain \[[@pone.0210008.ref006]\] and contained 1303 reactions, 1144 metabolites and 892 genes. Of the 4407 protein coding genes 61.3% were annotated for function, of which 20% were in the draft model. The reconstruction was transformed into a functional model with 1255 reactions and 971 metabolites and 858 genes representing *C*. *violaceum* metabolism. The curation involved systematic literature mining. Data mining through PubMed search engine resulted in 750 research articles related to *C*. *violaceum* (Fig A in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}). 472 papers provided evidence for gene protein reaction relationships and helped in model curation.

The SEED-derived *in silico C*. *violaceum* was unable to produce twenty six out of 74 biomass precursors \[[@pone.0210008.ref012],[@pone.0210008.ref013]\] with glucose as substrate. Sixty-nine reactions (Table E in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}) were added to allow biomass formation *in silico* based on experimental evidence for *C*. *violaceum* or phylogenetically related *N*. *meningitidis* (Tables B to D in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}). Twenty metabolites were added with "mDB" prefix and 143 reactions with "rDB" prefix. The average confidence score for the model was 1.45. The model statistics for *i*DB858 is presented in [Fig 1](#pone.0210008.g001){ref-type="fig"}. The model *i*DB858 successfully predicted the physiology of *C*. *violaceum* as per legacy data ([Table 1](#pone.0210008.t001){ref-type="table"}). A detailed description of the *in silico* representation of metabolic genome features of *C*. *violaceum* have been provided in Material B in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}.

![Model statistics and subsystem wise classification for *i*DB858.\
(A) Table for Model characteristics (B) A dot plot of the stoichiometric matrix for *i*DB858 with all 1330 reactions represented on X-axis and all 1004 metabolites on Y-axis. Each nonzero value is represented by a dot. (C) to (F) Pie charts representing categorization of reactions, reaction reversibility, gene protein associations (GPR) and metabolites, respectively. (G) Subsystems wise classification of the reactions present in the model.](pone.0210008.g001){#pone.0210008.g001}

10.1371/journal.pone.0210008.t001

###### Physiological characteristics successfully predicted by *i*DB858.

![](pone.0210008.t001){#pone.0210008.t001g}

  Physiological function     *In silico*   Experimental Reference           
  -------------------------- ------------- -------------------------------- --------------------------
  Lactate utilization        \+            Ron Taylor 2009                  
  Acetonitrile utilization   \+            Chapatwale 1988                  
  Glycerol utilization                     In house                         
  Violacein production       \+            Lichstein and Van de Sand 1945   
  Cyanide production         Glucose       \+                               Michaels and Corpe, 1965
  Succinate                  \+                                             
  Glutamate                  ++                                             

SEED draft model limitations {#sec004}
----------------------------

The SEED reconstruction did not reflect the complete biosynthetic pathways of amino acids and nucleotides present. Violacein biosynthesis (Table F in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}) critical and characteristic of *C*. *violaceum* \[[@pone.0210008.ref014]\] was also missing. The details of missing reactions added to the model are provided in Table A and Material A in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}. Thus automated draft reconstructions need detailed manual curation for refined reconstructions that can be translated to models to compute cell phenotype accurately.

Metabolic capacity validation of *i*DB858 based on BIOLOG GN2 plate phenotype {#sec005}
-----------------------------------------------------------------------------

The summarized metabolic reconstruction and modeling process is iterative ([Fig 2](#pone.0210008.g002){ref-type="fig"}). The GSMM reconstruction was converted into a model to compute growth/respiration phenotypes on several C/N sources. Predictions were validated using experimental high-throughput phenotypic array data (Biolog^™^) \[[@pone.0210008.ref015]--[@pone.0210008.ref017]\]. Failure modes were used to refine the model by adding 36 missing reactions. *i*DB858 was able to predict metabolic phenotypes of *C*. *violaceum* with a prediction accuracy of 89% ([Table 2](#pone.0210008.t002){ref-type="table"} and Table G in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}). Sensitivity of violacein biosynthesis to oxygen, NADPH, ATP demands and tryptophan were delineated using robustness analysis ([Fig 3](#pone.0210008.g003){ref-type="fig"}) to identify tryptophan and NADPH as bottlenecks using *i*DB858.

![Reconstruction of genome scale metabolic model.](pone.0210008.g002){#pone.0210008.g002}

![Robustness analysis.\
To understand metabolite limitation on biomass (A) and violacein (B) formation in *i*DB858 in glucose.](pone.0210008.g003){#pone.0210008.g003}

10.1371/journal.pone.0210008.t002

###### BIOLOG *in silico* prediction accuracy by *i*DB858.

![](pone.0210008.t002){#pone.0210008.t002g}

  ------------------ ----------------------------------------- ----------------------------------------------------------------------------------------
  Total Substrates   95                                        
  Not in Model       38                                        
  Present in Model   57                                        
  True Positive      37                                        
  True Negative      12                                        
  False Positive     2[^a^](#t002fn001){ref-type="table-fn"}   [^a^](#t002fn001){ref-type="table-fn"}Glycerol and Formate
  False Positive     4[^b^](#t002fn002){ref-type="table-fn"}   [^b^](#t002fn002){ref-type="table-fn"}D-serine, Uridine, 2-Aminoethanol, Cis-aconitate
  False Negative     2[^b^](#t002fn002){ref-type="table-fn"}   [^b^](#t002fn002){ref-type="table-fn"}Leucine, Glucose-1-phosphate
  ------------------ ----------------------------------------- ----------------------------------------------------------------------------------------

^**a**^Experimental evidence exists,

^**b**^Conflicting literature evidence

Growth prediction accuracy and ATP maintenance {#sec006}
----------------------------------------------

*i*DB858 predicted growth on 24 out of 27 exogenous metabolites tested (88.9% accuracy; [Table 3](#pone.0210008.t003){ref-type="table"} and Table H in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}). The inability to utilize citrate, oxalic acid and glyceraldehyde-3-phosphate was ascertained.

10.1371/journal.pone.0210008.t003

###### Exogenous metabolites *in silico* prediction accuracy by *i*DB858.

![](pone.0210008.t003){#pone.0210008.t003g}

  ------------------ -----------------------------------------
  Total Substrates   30
  Not in Model       1
  Present in Model   29
  True Positive      22
  True Negative      2
  False Negative     5[^a^](#t003fn001){ref-type="table-fn"}
  ------------------ -----------------------------------------

^a^Mannitol, Sorbitol, Tryptophan, Valine and Glutamine

The energy and maintenance requirements for instantaneous steady state vary when accounting for violacein yields in addition to biomass yields. The ATP maintenance requirements for wild type *C*. *violaceum* (WT) growing on glucose with violacein secretion decreased the maintenance costs (45%) for biomass synthesis from 12.59 to 6.96 mmol ATP per g of biomass. As a consequence if the violacein demand decreases, the ATP maintenance costs would increase. For wild type and resistant strains (ChlR and StrpR) and experimental conditions described here ([Table 4](#pone.0210008.t004){ref-type="table"}), the non-growth associated maintenance requirement was determined to be 6.96, 10.67 and 6.77 mmol of ATP per g of biomass respectively. This indicates lower violacein yields (as observed) for ChlR. Although StrpR had similar ATP maintenance costs, increased experimental yields of violacein indicate reprogramming of metabolism to compensate. Growth of WT *i*DB858 was under predicted by 19% and over predicted for ChlR and StrpR at fixed optimal oxygen uptake rates. Thus modulation of violacein yields and energy maintenance costs may be a metabolic signature of the action of these antibiotics. Similarly the ATP maintenance requirements for WT on pyruvate, succinate and D-malate were calculated as 3.62, 4.94 and 2.6 ATP per g of biomass respectively.

10.1371/journal.pone.0210008.t004

###### Experimental constraints used to define the three different population of *C*. *violaceum*.

![](pone.0210008.t004){#pone.0210008.t004g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Model   Glucose uptake rate[^a^](#t004fn001){ref-type="table-fn"}   Violacein\                                             Molar growth yield[^a^](#t004fn001){ref-type="table-fn"}   ATPM    Biomass\                                     Biomass\                                             Oxygen uptake rate
                                                                      secretion rate[^a^](#t004fn001){ref-type="table-fn"}                                                                      (*in-silico*)                                (*in-vitro*)[^a^](#t004fn001){ref-type="table-fn"}   
  ------- ----------------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------------- ------- -------------------------------------------- ---------------------------------------------------- --------------------
  WT      9.99                                                        1.49                                                   0.0312                                                     6.96    0.25                                         0.31                                                 21.58

  ChlR    10.53                                                       0.673                                                  0.0314                                                     10.67   0.68[^b^](#t004fn002){ref-type="table-fn"}   0.33                                                 9.91

  StrpR   12.78                                                       0.702                                                  0.0504                                                     6.77    0.92[^b^](#t004fn002){ref-type="table-fn"}   0.64                                                 17.03
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Experimental values.

^b^Constrain oxygen to lower the biomass predicted to match experimental biomass

Redox coupled metabolic flux redistribution a function of antibiotic perturbation in *C*. *violaceum* metabolic network {#sec007}
-----------------------------------------------------------------------------------------------------------------------

Flux variability analysis (FVA) was used to show perturbed central metabolism and redox balance in the presence of antibiotics and reprogrammed metabolism as compensatory mechanisms in resistant populations. To understand the effect of antibiotics on *C*. *violaceum* cellular metabolism the changes in feasible metabolic flux distributions in the presence of chloramphenicol (WT+chl) and streptomycin (WT+strep) were delineated using FVA and analysed (Tables [5](#pone.0210008.t005){ref-type="table"} and [6](#pone.0210008.t006){ref-type="table"}). Altered metabolism in WT in presence of chloramphenicol include overflow metabolism via secretion of acetate and formate. The rewiring of pyruvate formate lyase (PFL) to function unidirectionally leads to formate accumulation. Fumarate reductase (FRD7) carries a very negligible flux. FRD7 represents TCA as well as oxidative phosphorylation and is involved in relaying electrons towards cytochrome oxidase that eventually creates a PMF/ electrochemical membrane gradient for ATP synthesis. The failure of FRD7 to remain a control node in the presence of chloramphenicol indicates the continued use of O~2~ as terminal electron acceptor. The corresponding Electron Transport Chain (ETC) complex, represented by cytochrome oxidase bo3 carries a 12 fold lower flux compared to WT. Experimentally measured PMF using flow cytometry based membrane potential measurements is 10 fold higher measured ([Fig 4](#pone.0210008.g004){ref-type="fig"}) in the presence of chloramphenicol through potential disruption of the lipid bilayer and increased proton pumping through formate and acetate \[[@pone.0210008.ref018]\].

![Proton motive force (PMF) analysis using flow cytometry based membrane potential measurements for different metabolites including glucose, succinate, pyruvate, maleate and 2oxoadipate.\
More than three replicates were used with a standard deviation between 0.075 (glucose) to 0.35 (2 oxoadipate).](pone.0210008.g004){#pone.0210008.g004}

10.1371/journal.pone.0210008.t005

###### Flux variability analysis (FVA) to show the effect of chloramphenicol on WT.

![](pone.0210008.t005){#pone.0210008.t005g}

  Subsystem                   Reaction ID                               Reaction Formula                                         WT               WT+chl
  --------------------------- ----------------------------------------- -------------------------------------------------------- ---------------- ---------------------
  Glycolysis                  PYK                                       adp_c + pep_c -\> atp_c + pyr_c                          0.0005           0.76
  TCA Cycle                   FRD7                                      succ_c + q8_c \< = \> fum_c + q8h2_c                     5.13             -0.00039 to 0.00019
  Oxidative phosphorylation   cytochrome oxidase bo3 ubiquinol-8        2.5 h_c + 0.5 o2_c + q8h2_c -\> h2o_c + 2.5 h_e + q8_c   31.22            2.61
  Pyruvate metabolism         PFL                                       accoa_c + for_c \< = \> coa_c + pyr_c                    -10.84 to 0.23   -0.45
  PTAr                        h_c + accoa_c + pi_c -\> actp_c + coa_c   0.0001                                                   1.53             
  ACKr                        actp_c + adp_c -\> h_c + atp_c + ac_c     0.0001                                                   1.53             
                              EX_for                                    for_e \< = \>                                            0.0001           0.45
  EX_ac                       ac_e \< = \>                              0.0001                                                   1.53             

For reaction details and color code for the FVA category refer to [S1 Table](#pone.0210008.s002){ref-type="supplementary-material"}.

10.1371/journal.pone.0210008.t006

###### Flux variability analysis (FVA) to show the effect of streptomycin on WT.

![](pone.0210008.t006){#pone.0210008.t006g}

  Subsystem                                   Reaction ID                                                     Reaction Formula                                         WT               WT+strep
  ------------------------------------------- --------------------------------------------------------------- -------------------------------------------------------- ---------------- --------------
  TCA Cycle                                   AKGDH                                                           coa_c + nad_c + akg_c -\> co2_c + nadh_c + succoa_c      0.05             1.10
  FUM                                         mal\_\_L_c \< = \> fum_c + h2o_c                                -5.31                                                    -3.14            
  MDH                                         nad_c + mal\_\_L_c \< = \> h_c + nadh_c + oaa_c                 5.72                                                     2.04             
  Oxidative phosphorylation                   cytochrome oxidase bo3 ubiquinol-8                              2.5 h_c + 0.5 o2_c + q8h2_c -\> h2o_c + 2.5 h_e + q8_c   31.22            10.03
  Pyruvate metabolism                         PFL                                                             accoa_c + for_c \< = \> coa_c + pyr_c                    -10.84 to 0.23   -1.88 to 1.1
  PPS                                         atp_c + h2o_c + pyr_c -\> h_c + pi_c + pep_c + amp_c            0.0002                                                   0.15             
  Purine metabolism                           ATP carbamate phosphotransferase                                atp_c + co2_c + nh4_c \< = \> h_c + adp_c + cbp_c        0.17             1.10
  Folate biosynthesis                         MTHFD                                                           nadp_c + mlthf_c \< = \> nadph_c + methf_c               0.41             1.10
  FTHFD                                       h2o_c + 10fthf_c -\> h_c + for_c + thf_c                        0.22                                                     1.10             
  Glutamate metabolism                        ASPTA                                                           asp\_\_L_c + akg_c \< = \> oaa_c + glu\_\_L_c            -0.63            -1.10
  Glycine, Serine and Threonine metabolism    PSERT                                                           akg_c + pser\_\_L_c \< = \> glu\_\_L_c + 3php_c          -3.54            -1.10
  GHMT                                        gly_c + h2o_c + mlthf_c \< = \> ser\_\_L_c + thf_c              -0.46                                                    -1.10            
  Arginine and proline metabolism             PRO1x                                                           h_c + nadh_c + 1pyr5c_c -\> nad_c + pro\_\_L_c           0.35             0.002
  SOTA                                        akg_c + sucorn_c \< = \> sucgsa_c + glu\_\_L_c                  4e-5                                                     1.10             
  SGSAD                                       h2o_c + nad_c + sucgsa_c -\> 2 h_c + nadh_c + sucglu_c          4e-5                                                     1.10             
  SGDS                                        h2o_c + sucglu_c \< = \> succ_c + glu\_\_L_c                    4e-5                                                     1.10             
  AST                                         arg\_\_L_c + succoa_c -\> h_c + coa_c + sucarg_c                4e-5                                                     1.10             
  Urea cycle and metabolism of amino groups   ARGSL                                                           argsuc_c -\> fum_c + arg\_\_L_c                          0.07             1.10
  ARGSS_1                                     atp_c + asp\_\_L_c + citr\_\_L_c -\> ppi_c + argsuc_c + amp_c   0.07                                                     1.10             
  AGGPR                                       nadph_c + acg5p_c -\> pi_c + nadp_c + acg5sa_c                  0.08                                                     1.10             
  OCBT                                        cbp_c + orn_c -\> 2 h_c + pi_c + citr\_\_L_c                    0.07                                                     1.10             
  ORNTAC                                      glu\_\_L_c + acorn_c \< = \> orn_c + acglu_c                    0.08                                                     1.10             
  ACGK                                        h_c + atp_c + acglu_c -\> adp_c + acg5p_c                       0.08                                                     1.10             
  ACOTA                                       glu\_\_L_c + acg5sa_c -\> akg_c + acorn_c                       0.08                                                     1.10             
  Cyanoamino Metabolism                       glycine:acceptor oxidoreductase                                 gly_c + 2 nadph_c -\> co2_c + 2 nadp_c + hcn_c           0.28             1.10
  cyn_rxn6                                    hcn_c -\> acybut_c                                              0.28                                                     1.10             
                                              NH4+ Exchange                                                   nh4_e \< = \>                                            -6.28            1.09

For reaction details and color code for the FVA category refer to [S1 Table](#pone.0210008.s002){ref-type="supplementary-material"}.

In the presence of streptomycin however, higher ammonia and cyanide are produced and siphoned off to make more glutamate and glycine as seen experimentally and varied folate metabolism (through increased p-aminobenzoic acid) \[[@pone.0210008.ref011]\]. Lysine, methionine, histidine correlated to the altered function (via mutation) of the PLP utilizing PabC. Glutamate efflux (experimental data and Succinylornithine transaminase, SOTA reaction directionality in [Table 6](#pone.0210008.t006){ref-type="table"}) have been implicated previously in streptomycin induced decreased cell viability \[[@pone.0210008.ref019]\]. These results are validated by the metabolite profiling data from our previous study \[[@pone.0210008.ref011]\]. The increased flux towards tetrahydrofolate synthesis with co-synthesis of formate (Formyltetrahydrofolate amidohydrolase, FTHFD in [Table 6](#pone.0210008.t006){ref-type="table"}) is potentially rechanneled through the folate pathway instead of formate secretion. Around 5% (68) of the total reactions including 11 redox coupled reactions spanning 16 different subsystems showed differential flux distribution for the antibiotic presence (Fig F in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}). These 11 redox coupled reactions (involving NADH/NADPH) show that there is increased accumulation of NADH in the presence of streptomycin as compared to chloramphenicol that was confirmed by experimental quantitation of NAD/NADH levels \[[@pone.0210008.ref011]\]. This could potentially lead to pseudo-hypoxia even in the presence of normal oxygen levels. These changes observed *in silico* as well as *in vitro*, confirms modulation of flux involving NADH. FRD7 is reduced 2.5 fold. ATP generation is almost three fold lower through the ETC-PMF route similar to that of WT. The PMF is a third of that observed in the wild type ([Fig 4](#pone.0210008.g004){ref-type="fig"}) and correlates well to the 3 fold decrease in unique flux held by the cytochrome oxidase bo3 reaction.

Compensatory metabolic reprogramming as a survival strategy in resistant population {#sec008}
-----------------------------------------------------------------------------------

The metabolic reprogramming due to antibiotic selection pressures was analysed by FVA using customized models to represent WT, ChlR and StrpR (Tables [7](#pone.0210008.t007){ref-type="table"} and [8](#pone.0210008.t008){ref-type="table"}). Differences in unique forced fluxes/rates between resistant and susceptible populations in central metabolic pathways indicate compensatory metabolic reprogramming. Both the resistant populations resort to overflow metabolism towards acetate. Isocitrate lyase (ICL), the glyoxylate shunt enzyme implicated in pathogenesis and persistence in *Salmonella* and resistance in *Mycobacterium* \[[@pone.0210008.ref020]\] shunts isocitrate by bypassing part of the TCA cycle. The glyoxylate shunt functions in case of StrpR but TCA continues through oxidative branch in case of ChlR. In case of StrpR higher flux through pyrimidine metabolism is represented by cytidylate kinase (CYTK1 in [Table 8](#pone.0210008.t008){ref-type="table"}) that correlated well with previously published liquid chromatography---mass spectrometry (LCMS) data showing higher average relative flux of cytosine and adenosine in StrpR \[[@pone.0210008.ref011]\]. The flux through cytochrome oxidase (oxidative phosphorylation) is reduced by 50%. This potentially reduced the membrane potential by half ([Fig 4](#pone.0210008.g004){ref-type="fig"}) as captured by flow cytometry analysis. Lowering iron homeostasis has been recently implicated as one mechanism that plays a critical role in antibiotic mediated cell death and evolution of *de novo* antibiotic resistance \[[@pone.0210008.ref021],[@pone.0210008.ref022]\]. The iron related oxygen oxidoreductase reprogrammed to increase Fe^+2^ indicates lower probability of Fenton reaction and DNA mutations. The lowered oxygen uptake rate and the increased flux towards NADH, potentially represent a pseudohypoxic state. Lowered ratios of NAD+/NADH increase pyruvate dehydrogenase (PDH) phosphorylation and modulate pyruvate and acetate levels. In the presence of chloramphenicol, the ChlR population growing on glucose maintained the NAD/NADH ratio at 0.28 while in the presence of streptomycin, the StrpR population maintained the NAD/NADH ratio at 2.47. Potentially, the PDH must be completely dephosphorylated in the ChlR (supporting acetate and formate overflow) as compared to StrpR (only acetate overflow) to evoke such a response.

10.1371/journal.pone.0210008.t007

###### Flux variability analysis (FVA) to show compensation in case of ChlR.

![](pone.0210008.t007){#pone.0210008.t007g}

  Subsystem                                 Reaction ID                                             Reaction Formula                                         WT        ChlR
  ----------------------------------------- ------------------------------------------------------- -------------------------------------------------------- --------- ---------
  Glycolysis                                PYK                                                     adp_c + pep_c -\> atp_c + pyr_c                          0.001     1.44
  TCA                                       SUCOAS                                                  atp_c + coa_c + succ_c -\> adp_c + pi_c + succoa_c       4e-5      0.07
  MDH                                       nad_c + mal\_\_L_c \< = \> h_c + nadh_c + oaa_c         5.72                                                     0.22      
  ICDHyrb                                   nadp_c + icit_c \< = \> h_c + mDB_oxasucc_c + nadph_c   0.00005                                                  0.0038    
  Oxidative phosphorylation                 cytochrome oxidase bo3                                  2.5 h_c + 0.5 o2_c + q8h2_c -\> h2o_c + 2.5 h_e + q8_c   31.22     14.42
  Pyruvate metabolism                       PTAr                                                    h_c + accoa_c + pi_c -\> actp_c + coa_c                  0.0001    11.78
  ACKr                                      actp_c + adp_c -\> h_c + atp_c + ac_c                   0.0001                                                   11.78     
  PFL                                       accoa_c + for_c \< = \> coa_c + pyr_c                   -10.84 to 0.23                                           -9.58     
  PPC                                       co2_c + h2o_c + pep_c -\> 2 h_c + pi_c + oaa_c          0.0001                                                   0.60      
  Glyoxylate and dicarboxylate metabolism   ICL                                                     icit_c \< = \> succ_c + glx_c                            5.09      -0.004
  Purine metabolism                         ADK2                                                    h_c + amp_c + pppi_c -\> ppi_c + adp_c                   0.0007    0.001
  Pyrimidine metabolism                     CYTK1                                                   atp_c + cmp_c -\> adp_c + cdp_c                          0.06      0.08
  Porphyrin and chlorophyll metabolism      FeII oxygen oxidoreductase                              4 h_c + o2_c + 4 fe2_c \< = \> 2 h2o_c + 4 fe3_c         0.00005   -0.0007
  Extracellular Transport                   EX_ac_e                                                 ac_e \< = \>                                             0.0001    11.82
  EX_for_e                                  for_e \< = \>                                           0.0001                                                   9.80      

For reaction details and color code for the FVA category refer to [S1 Table](#pone.0210008.s002){ref-type="supplementary-material"}.

10.1371/journal.pone.0210008.t008

###### Flux variability analysis (FVA) to show compensation in case of StrpR.

![](pone.0210008.t008){#pone.0210008.t008g}

  Subsystem                                 Reaction ID                                              Reaction Formula                                         WT               StrpR
  ----------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ---------------- --------
  Glycolysis/Gluconeogenesis                PYK                                                      adp_c + pep_c -\> atp_c + pyr_c                          0.001            1.61
  TCA Cycle                                 AKGDH                                                    coa_c + nad_c + akg_c -\> co2_c + nadh_c + succoa_c      0.05             0.14
  MDH                                       nad_c + mal\_\_L_c \< = \> h_c + nadh_c + oaa_c          5.72                                                     1.58             
  Oxidative phosphorylation                 cytochrome oxidase bo3 ubiquinol-8                       2.5 h_c + 0.5 o2_c + q8h2_c -\> h2o_c + 2.5 h_e + q8_c   31.22            28.42
  Pyruvate metabolism                       PTAr                                                     h_c + accoa_c + pi_c -\> actp_c + coa_c                  0.0001           11.76
  ACKr                                      actp_c + adp_c -\> h_c + atp_c + ac_c                    0.0001                                                   11.76            
  ACALD                                     acald_c + coa_c + nad_c \< = \> h_c + accoa_c + nadh_c   0.0007                                                   0.002            
  PFL                                       accoa_c + for_c \< = \> coa_c + pyr_c                    -10.84 to 0.23                                           -14.53 to 0.59   
  MALS                                      accoa_c + h2o_c + glx_c -\> h_c + coa_c + mal\_\_L_c     5.10                                                     0.51             
  ME2                                       nadp_c + mal\_\_L_c -\> co2_c + nadph_c + pyr_c          4.69                                                     0.00004          
  PPC                                       co2_c + h2o_c + pep_c -\> 2 h_c + pi_c + oaa_c           0.0001                                                   0.54             
  Glyoxylate and dicarboxylate metabolism   ICL                                                      icit_c \< = \> succ_c + glx_c                            5.09             0.50
  Pyrimidine metabolism                     CYTK1                                                    atp_c + cmp_c -\> adp_c + cdp_c                          0.06             0.16
  Porphyrin and chlorophyll metabolism      FeII oxygen oxidoreductase                               4 h_c + o2_c + 4 fe2_c \< = \> 2 h2o_c + 4 fe3_c         0.00005          -0.001
  Extracellular Transport                   EX_ac_e                                                  ac_e \< = \>                                             0.0001           11.85

For reaction details and color code for the FVA category refer to [S1 Table](#pone.0210008.s002){ref-type="supplementary-material"}.

The NAD/NADH ratios in the wild type were around 0.25 for glucose and pyruvate, while it was 0.73 for succinate and oxoadipate. The ChlR strain shows major 7 fold reduction indicating high levels of NAD recycling provided by pyruvate. Concurrently, PMF/membrane potential is higher for the resistant populations in pyruvate as compared to the wild type. This suggests potential incapability to maintain ATP homeostasis under these conditions and an eventually complete decoupling of electron transfer and ATP synthesis. Similar results were observed for succinate, maleate and 2-oxoadipate.

Decoupling NADH oxidation from respiratory energy generation using in silico water forming NADH oxidase (NOX) {#sec009}
-------------------------------------------------------------------------------------------------------------

NADH oxidase (NOX) allows dissecting the role of redox imbalance and ATP synthesis deficiency in ETC function \[[@pone.0210008.ref023]\]. The flux through NOX (at constant GUR) indicates the need to recycle excess 13.2 and 10.31 mmol NADH per gDW of biomass for redox balance in ChlR and StrpR respectively ([Table 9](#pone.0210008.t009){ref-type="table"}). This underscores the importance of NAD+ recycling to maintain growth in both resistant populations. Since converting NADH to NAD+, NOX also consumes protons and oxygen, oxygen consumption (OUR) in ChlR and StrpR strains increased by 170% and 86% respectively. In the absence of NOX, the reduced apparent OUR indicate pseudo-hypoxia as previously reported \[[@pone.0210008.ref024]\]. Although the ATPM for StrpR is similar to that of WT (6.77 compared to 6.96), a significant flux (10.31) through NOX is essential to attain experimental growth yields. This suggests decoupled redox homeostasis and PMF in StrpR.

10.1371/journal.pone.0210008.t009

###### Constraints used for NADH oxidase (NOX) simulations for ChlR and StrpR.

![](pone.0210008.t009){#pone.0210008.t009g}

  Model   Glucose uptake rate   Violacein secretion rate   ATPM    Biomass   Oxygen uptake rate   NOX     
  ------- --------------------- -------------------------- ------- --------- -------------------- ------- ---
  ChlR    10.53                 0.673                      10.67   0.68      0.33                 9.91    0
  0.68    0.33                  26.53                      13.2                                           
  StrpR   12.78                 0.702                      6.77    0.92      0.64                 17.03   0
  0.92    0.64                  31.7                       10.31                                          

FVA of the three populations (WT, ChlR and StrpR) in presence of NOX provided an insight into NAD+ recycling associated metabolic reprogramming in the resistant populations. Based on the feasible flux distributions, the resistant populations behaved very similar to the wild type ([Table 10](#pone.0210008.t010){ref-type="table"}). Metabolic reprogramming via NAD recycling ([Table 10](#pone.0210008.t010){ref-type="table"}, yellow) were identified along with overflow metabolism. Introduction of NOX alone in StrpR supported WT-like phenotypes but for ChlR ([Table 10](#pone.0210008.t010){ref-type="table"}, red) varied ATPM maintenance was also critical. This confirms decoupled redox electron transfer and ATP synthesis in StrpR.

10.1371/journal.pone.0210008.t010

###### Flux variability analysis (FVA) category changes post NADH oxidase (NOX) addition to ChlR and StrpR models of *C*. *violaceum*.

![](pone.0210008.t010){#pone.0210008.t010g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subsystem                                                     Reaction ID                                       WT   ChlR[^d^](#t010fn005){ref-type="table-fn"}   StrpR[^d^](#t010fn005){ref-type="table-fn"}   ChlR[^e^](#t010fn006){ref-type="table-fn"}   StrpR[^e^](#t010fn006){ref-type="table-fn"}   ChlRN\                                     StrpR\                                      ChlR\                                       StrpR\
                                                                                                                                                                                                                                                                                                             ox[^d^](#t010fn005){ref-type="table-fn"}   Nox[^d^](#t010fn005){ref-type="table-fn"}   Nox[^e^](#t010fn006){ref-type="table-fn"}   Nox[^e^](#t010fn006){ref-type="table-fn"}
  ------------------------------------------------------------- ------------------------------------------------- ---- -------------------------------------------- --------------------------------------------- -------------------------------------------- --------------------------------------------- ------------------------------------------ ------------------------------------------- ------------------------------------------- -------------------------------------------
  TCA Cycle                                                     MDH[^a^](#t010fn002){ref-type="table-fn"}         2    1                                            1                                             2                                            1                                             2                                          2                                           2                                           2

  CS[^b^](#t010fn003){ref-type="table-fn"}                      1                                                 7d   1                                            7d                                            1                                            1                                             1                                          1                                           1                                           

  SUCOAS[^b^](#t010fn003){ref-type="table-fn"}                  7d                                                1    7d                                           1                                             7d                                           7d                                            7d                                         7d                                          7d                                          

  FRD7[^b^](#t010fn003){ref-type="table-fn"}                    2                                                 8    2                                            8                                             2                                            2                                             2                                          2                                           2                                           

  AKGDH[^b^](#t010fn003){ref-type="table-fn"}                   3                                                 7d   3                                            7d                                            3                                            3                                             3                                          3                                           3                                           

  Pyruvate metabolism                                           ME2[^a^](#t010fn002){ref-type="table-fn"}         3    7d                                           7d                                            7d                                           7d                                            3                                          3                                           3                                           3

  PPC[^a^](#t010fn002){ref-type="table-fn"}                     7d                                                1    1                                            2                                             1                                            7d                                            7d                                         7d                                          7d                                          

  OAADC[^a^](#t010fn002){ref-type="table-fn"}                   3                                                 7d   7d                                           7d                                            7d                                           3                                             3                                          3                                           3                                           

  PFL[^b^](#t010fn003){ref-type="table-fn"}                     8                                                 5    8                                            5                                             8                                            8                                             8                                          8                                           8                                           

  MALS[^b^](#t010fn003){ref-type="table-fn"}                    1                                                 7d   1                                            7d                                            1                                            1                                             1                                          1                                           1                                           

  Glyoxylate & dicarboxylate metabolism                         ICL[^b^](#t010fn003){ref-type="table-fn"}         1    4                                            1                                             4                                            1                                             1                                          1                                           1                                           1

  Glutathione metabolism                                        AMPTASECG[^c^](#t010fn004){ref-type="table-fn"}   7b   5                                            4                                             7b                                           4                                             4                                          4                                           7b                                          4

  glutathione hydralase[^c^](#t010fn004){ref-type="table-fn"}   7b                                                5    4                                            7b                                            4                                            4                                             4                                          7b                                          4                                           

  Extracellular Transport                                       Ex_for_e[^b^](#t010fn003){ref-type="table-fn"}    7d   1                                            7d                                            2                                            7d                                            7d                                         7d                                          7d                                          7d
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

For FVA category color code refer to [S1 Table](#pone.0210008.s002){ref-type="supplementary-material"}.

^a^Reactions common to both resistant population

^**b**^Reactions unique to ChlR

^**c**^Reactions unique to ChlR when WT ATPM was used

^d^FVA using their respective ATPM values

^e^FVA using the WT ATPM value

Gene essentiality and synthetic lethality {#sec010}
-----------------------------------------

Gene essentiality analysis for growth and biomass precursors ([Fig 5A](#pone.0210008.g005){ref-type="fig"}) identified 191 virulent genes ([Table 11](#pone.0210008.t011){ref-type="table"}) minimally required for survival in glucose medium aerobically. 644 genes were predicted as avirulent and 23 attenuated genes resulting in 36% to 98% reduction in growth. Conditional dependent essentiality was assessed on C-source metabolites pyruvate, succinate, maleate, D-malate and 2-oxoadipate ([Fig 5B and 5C](#pone.0210008.g005){ref-type="fig"}), candidates for re-sensitization of ChlR and StrpR to antibiotics. 191 genes belonging to different subsystems were predicted essential for glucose and other substrates (Fig E in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}). Nine essential genes were substrate independent ([Fig 5C](#pone.0210008.g005){ref-type="fig"}). These included five genes from glycolysis and anaplerosis (for pyruvate). 3 additional genes essential for growth on 2-oxoadipate were a part of TCA, tryptophan metabolism and valine, leucine and isoleucine degradation subsystem.

![Gene deletion analysis.\
(A) Heat map for single gene deletion (SGD) analysis for biomass precursors. (B) Heat map and table (C) for SGD analysis for 5 candidate metabolites along with glucose. (D) Heat map for double gene deletion (DGD) analysis on glucose under aerobic condition. (E and F) Unique genes involved in synthetic lethal pair interaction during DGD analysis. (G) Synthetic lethal pair interactions for two or more connectivity, highest connectivity observed in case of upper glycolysis and Entner Duordoff pathway.](pone.0210008.g005){#pone.0210008.g005}

10.1371/journal.pone.0210008.t011

###### Single gene deletion analysis of *i*DB858 on glucose under aerobic condition.

![](pone.0210008.t011){#pone.0210008.t011g}

  Category          GR Ratio       Genes
  ----------------- -------------- -------
  Attenuated        0.36 to 0.98   23
  Virulent genes    0              191
  Avirulent genes   0.99 to 1      644

Double gene deletion (DGD) analysis ([Fig 5D to 5G](#pone.0210008.g005){ref-type="fig"}) led to identification of 186 genes in 518 combinations resulting in synthetic lethal (SL) and sick (SS) interactions. Synthetic lethal and sick interactions predicted that 129 genes involved in synthetic lethal pairs were related to porphyrin metabolism, phenylalanine, tyrosine and tryptophan biosynthesis and purine metabolism. CV_0939, *tpiA* had the highest connectivity. CV_1071 involved in utilization of 2oxoadipate (resensitisation candidate) utilization was synthetically lethal with two genes from the TCA cycle (CV_1075 or CV_1076). This might explain the criticality of TCA (central metabolism) in resensitising the resistant population to 2 oxoadipate. The synthetic lethal pairs can be utilized for predicting drug targets that would otherwise be extremely challenging (possible pairs based on 858 genes---7,36,164) to test experimentally. All the simulation results and *i*DB858 model have been provided in supporting information.

Discussion {#sec011}
==========

Antibiotic lethality may be initiated by altered cellular redox state. The redox stress potentially rewires central metabolism, cellular respiration, and iron resulting in cellular damage \[[@pone.0210008.ref025]\]. Our work exemplifies how systems-level analyses can help dissect the complexity involved in oxidative phosphorylation and electron transfer in responses to drugs.

A whole genome-scale metabolic model of *Chromobacterium violaceum*, *i*DB858 was generated that predicted response to antibiotics and metabolic reprogramming in resistant populations. FVA identified rewired central and redox metabolism in the presence of antibiotics and resistant populations all represented by *in silico* constraints. The relative contributions of redox imbalance and ATP insufficiency contributing to antibiotic action were delineated. *i*DB858 showed all redox coupled reactions carried uniquely determined flux confirming the critical role of redox homeostasis in maintaining viability and cellular function in *C*. *violaceum* as seen experimentally \[[@pone.0210008.ref025]--[@pone.0210008.ref029]\]. This also correlated well with the differential NADH/NAD ratios obtained for the resistant and susceptible populations \[[@pone.0210008.ref011]\]. The metabolic rewiring in *i*DB858 as a response to chloramphenicol or streptomycin resulted in overflow metabolism. Compensations in resistant populations included overflow metabolism to acetate and formate in ChlR but only acetate in StrpR. StrpR bypassed the oxidative branch of TCA and redirected metabolism to the glyoxylate shunt (ICL, MALS) seen in *Salmonella* persisters.

Addition of NOX (essentially a sink for NADH) to *i*DB858 also captured for the first time the metabolic flux distributions related to NAD+ recycling. This is key for survival of ChlR and StrpR *in silico*. The Pareto optimality analysis of ATP and NADH maintenance in *i*DB858 identified decoupled electron transfer and ATP synthesis in case of StrpR but not in ChlR. This is first of a kind study that shows such decoupling in ETC function in aminoglycoside antibiotic resistant populations.

Although we were able to understand re-sensitization of resistant population in presence of 2-oxoadipate by synthetic lethal pair analysis, further experimental validation is critical to identify more such candidates for inducing death in *C*. *violaceum*.

Quite recently constraints-based flux balance analysis of metabolic models is gaining momentum to understand "emergent phenomena" of antibiotic resistance \[[@pone.0210008.ref011],[@pone.0210008.ref030]--[@pone.0210008.ref032]\]. In our knowledge this is the first study that uses genome-scale models and specific redox based objectives to identify metabolic reprogramming and redox homeostasis as compensations to antibiotic selections pressures. Integrating growth, metabolite and minimum inhibitory concentration (MIC) profiling along with constraints-based models could potentially be clinically translated to human pathogens such as ESKAPE (*Enterococcus faecium*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, *and Enterobacter* species). Such approaches are scalable and show promise to identify candidate substrates for re-sensitization and understand complex emergent phenomena like antibiotic resistance.

Materials and methods {#sec012}
=====================

Bacterial strains and growth conditions {#sec013}
---------------------------------------

*Chromobacterium violaceum* strain ATCC 12472,wild type, (*C*. *violaceum* or WT) was obtained from the American Type Culture Collection Center (ATCC), USA and routinely cultured on Luria- Broth (LB, Hi-Media-M575) at 30 °C with continuous aeration in a shaker incubator set at 180 revolutions per minute (rpm). Antibiotic resistant strains ChlR and StrpR of *C*. *violaceum* were evolved in our previous study \[[@pone.0210008.ref011]\] under controlled laboratory environments using the two antibiotics, chloramphenicol (chl) and streptomycin (strep) respectively, at sub-lethal concentrations (10 μg/mL) on Luria Bertani agar (LBA) plates. These strains were cultured in LB with antibiotic (10 μg/mL) at 30 °C with continuous aeration in a shaker incubator set at 180 rpm.

Membrane potential measurements {#sec014}
-------------------------------

BacLight Bacterial Membrane Potential Kit (B34950, Invitrogen) was used to measure changes in PMF induced by antibiotic for all three population of *C*. *violaceum* according to the manufacturer's instructions. Briefly, stationary cells cultured in presence of different metabolites were diluted to 10^6^ CFU/mL and stained with 10 μL of 3 mM DiOC2 (3), incubated for 30 min. Samples were analyzed using a BD LSR Fortessa SORP cell analyzer flow cytometer (Becton Dickinson, San Jose, CA) with optimized settings. The membrane potential was normalized as the intensity ratio of red fluorescence (a membrane potential- dependent signal) and green fluorescence (a membrane potential-independent signal). The measurements were made for Glucose, Pyruvate, 2oxoADP, Maleate and Succinate. Seven replicates were used for glucose with a standard deviation of 0.075 whereas three replicates were used for the other substrates with standard deviations of 0.14, 0.35, 0.095 and 0.145 respectively. Relative PMF was determined in test samples compared to positive control samples (with glucose) and negative control samples (+CCCP).

Genome annotation {#sec015}
-----------------

The complete genome sequence and annotation of *C*. *violaceum* ATCC 12472, GenBank accession number AE016825.1 \[[@pone.0210008.ref006]\], available online at National Center for Biotechnology Information (<http://www.ncbi.nlm.nih.gov>) was imported into the RAST server (<http://rast.nmpdr.org/>) for gene calling and annotation with subsequent manual inspection and curation. This information was used in the metabolic network reconstruction and validation processes.

Reconstruction of *C*. *violaceum* metabolic network {#sec016}
----------------------------------------------------

[Fig 2](#pone.0210008.g002){ref-type="fig"} provides an overview of the genome-scale metabolic reconstruction pipeline of *C*. *violaceum*. The protocol for reconstruction of genome-scale metabolic models (GSMM) \[[@pone.0210008.ref033]\] was followed and the model name, *i*DB858, was based on existing convention for naming GSMMs \[[@pone.0210008.ref034]\], 858 representing the number of genes. Thermodynamically infeasible cycles (e.g. cycles resulting in free ATP production) were identified and removed and all reactions checked for mass- and charge-balance. The resulting model was then tested by comparing model predictions to available BIOLOG data \[[@pone.0210008.ref015]--[@pone.0210008.ref017]\]. Reactions manually identified, were added when sufficient evidence was available from experimental data, NCBI, KEGG, MetaCyc, BioCyc, BRENDA and SEED databases.

Initial draft reconstruction {#sec017}
----------------------------

An initial draft genome-scale reconstruction of *C*. *violaceum* was built using the RAST server and Model SEED Server (<http://www.theseed.org/models/>) \[[@pone.0210008.ref035],[@pone.0210008.ref036]\]. The objective function for biomass in the SEED reconstruction was modified to reflect the actual macromolecular composition. After modifying the nutrient and biomass composition of the model to accurately capture the boundary conditions that define the overall phenotype, the internal network was curated.

Manual curation for biomass prediction {#sec018}
--------------------------------------

The initial draft reconstruction downloaded from Model SEED, was not able to generate biomass using minimal media or a richer chemically defined media. 27 precursors of biomass not forming *in silico* were identified through manual curation. The manually added reactions begin with "rDB" prefix in the model.

Translation to BiGG database format and consistency check {#sec019}
---------------------------------------------------------

The SEED reactions and metabolites were matched with KEGG reaction IDs represented in KEGG database (<http://www.kegg.jp/>) or to the IDs available on BiGG database (<http://bigg.ucsd.edu/>) to maintain acceptable and clear standards of constraint-based models \[[@pone.0210008.ref037]\]. Gene annotations were converted from peg IDs to the respective CV gene IDs. Various consistency checks were also performed such as for directionality, occurrence of blocked genes, gaps, orphan metabolites as well as mass and charge balance.

Biomass composition {#sec020}
-------------------

Biomass biosynthesis was set as a linear combination of the macromolecules protein, DNA, RNA, lipid, peptidoglycan and LPS, considered to account for the overall biomass composition. A detailed calculation of the biomass composition and its assembly using legacy data is mentioned in Tables B and C and complete breakup is available in Table D in [S1 File](#pone.0210008.s001){ref-type="supplementary-material"}.

Flux balance analysis (FBA) {#sec021}
---------------------------

Implementation of the GSMM for *C*. *violaceum* and constraints-based analysis was done using Constraints Based Reconstruction and Analysis (COBRA) Toolbox 2.0.2 \[[@pone.0210008.ref038]\] with MATLAB v 7.11, (R2010b) and TOMLAB/CPLEX v7.7 optimizer. MATLAB codes for all referenced COBRA functions are available at the COBRA's website (<https://opencobra.github.io/>). The function optimizeCbModel(), in COBRA toolbox was used to simulate for growth (maximize biomass objective function) and violacein production as reported earlier \[[@pone.0210008.ref011]\] using flux balance analysis (FBA).

Validation of the metabolic model {#sec022}
---------------------------------

Validation of *i*DB858 was performed in part by simulating for growth and respiration on metabolites that are potential carbon and nitrogen sources. The predictions were validated using legacy (BIOLOG) substrate utilization data. Predictions of the model for simultaneous growth and violacein production on 30 substrates were validated experimentally.

Metabolic model of WT, ChlR and StrpR populations {#sec023}
-------------------------------------------------

A set of constraints that define the antibiotic susceptible WT and the evolved populations (ChlR and StrpR) were used to customize the models to represent antibiotic susceptible and resistant *Chromobacterium*. The constraints used were experimentally measured in our previous study \[[@pone.0210008.ref011]\] as shown in [Table 4](#pone.0210008.t004){ref-type="table"} and included Glucose uptake and Violacein secretion rates (GUR, VSR), Growth yields, and ATP maintenance costs associated with molar growth yields of each strain. The specific growth rates were calculated using 1g biomass as basis.

Robustness analysis {#sec024}
-------------------

Robustness analysis, using robustnessAnalysis() was used to better understand the sensitivity of growth and violacein phenotype of *C*. *violaceum* to different environmental perturbations such as oxygen uptake, NADPH, tryptophan, ATP demand.

Flux variability analysis (FVA) {#sec025}
-------------------------------

FVA (set up using fluxVariability()) calculates minimum and maximum flux values for each reaction in the model subject to constraints for specific objectives \[[@pone.0210008.ref039]\]. Differences in antibiotic sensitive and resistant population flux distributions were classified based on flux magnitude and direction defining rigidity or flexibility \[[@pone.0210008.ref011]\]. Changing directionality of a reversible reaction or modulating magnitude/span of the reaction flux indicated metabolic reprogramming. FVA was performed in the presence and absence of NADH oxidase (NOX).

NADH oxidase simulations {#sec026}
------------------------

A reaction representing NADH oxidase (water forming) was added to the model to delineate the role of NADH imbalance and show decoupling of electron transfer via Electron Transport Chain (ETC) and proton pumping for ATP synthesis \[[@pone.0210008.ref023]\]. This reaction acts essentially as a drain if there is excess NADH in the system and is represented as: $$\left. 2\mspace{720mu}\text{h}\_\text{c} + 2\mspace{720mu}\text{nadh}\_\text{c} + \text{o}2\_\text{c}\rightarrow 2\mspace{720mu}\text{h}2\text{o}\_\text{c} + 2\mspace{720mu}\text{nad} \right.\_\text{c}$$

Analysis of Pareto fronts and trade-off between ATP and NADH maintenance reactions was performed by constraining the GUR, VSR and the growth yield to experimental values and maximizing the fluxes through the generic ATPase (ATPM) and NADH oxidase reaction (NOX).

Gene essentiality and synthetic lethal analysis in *C*. *violaceum* {#sec027}
-------------------------------------------------------------------

Gene essentiality or lethality was predicted using the function singleGeneDeletion(), \[[@pone.0210008.ref040]\]. *In silico* virulent genes are those that are essential for *C*. *violaceum* growth. Non-essential or avirulent genes and attenuated genes lower growth vis a vis wild type on deletion \[[@pone.0210008.ref040]\]. Epistatic interactions were identified using doubleGeneDeletion() and delineating synthetic lethal (SL) and synthetic sick (SS) gene pairs.

Supporting information {#sec028}
======================

###### Supplemental figures, tables and text.

Supporting figures, tables and additional information regarding manual curation, model features and selected simulations of *i*DB858.

(PDF)

###### 

Click here for additional data file.

###### Supporting large tables and datasets.

Supporting information related to the simulations done using the genome scale metabolic model of *C*. *violaceum*, *i*DB858 using COBRA Toolbox as described in material and methods.

(XLSX)

###### 

Click here for additional data file.

###### *i*DB858.

The .mat file for the genome scale model of *C*. *violaceum*, *i*DB858 used on MATLAB platform for all the simulations reported in this manuscript.

(MAT)

###### 

Click here for additional data file.
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